Physicians' Academy for Cardiovascular Education

Evidence for effects of older glucose-lowering agents on CV risk

Slides (curriculum) - Sep. 5, 2015

A slide lecture program on glucose lowering agents on CV risk, like: metformin, sulphonylureas, TZDs, and a rationale for FDA guidance.

Developed and provided by the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS), an initiative from Boehringer Ingelheim & Lilly and published as an educational service with permission at PACE-CME

To download slides

Download PACE ACROSS T2D Module C_11Aug15.pptx

To view slides click on images

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: